Search

everythinglearnresearchcommunity

for

Search:↓

Some women with excess hair growth have a hormone condition that can't be diagnosed by blood or urine tests alone.

Non-classic congenital adrenal hyperplasia is a common disorder causing symptoms like acne and infertility, and it's managed based on symptoms, not just test results. Treatment can improve fertility and reduce miscarriage risk.

Cyproterone acetate with estradiol may subjectively improve excessive hair growth in women, but it's not clinically better than other treatments.

Cyproterone acetate is an effective treatment for women with acne, hair loss, and excessive hair growth.

A new mutation in the CYP11B1 gene was found in a woman with mild hyperandrogenemia, a rare cause of non-classic congenital adrenal hyperplasia.

Finasteride and CPA-EE2 equally reduce hirsutism, but affect hormone levels differently.

Cyproterone acetate effectively treats virilized women, especially under 35, despite some side effects.

The treatment reduced hair growth and testosterone in women with excess hair and had some effects on stress responses.

Congenital Adrenal Hyperplasia is mainly caused by enzyme deficiencies, leading to varying symptoms like hormone imbalances and physical changes.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

The document suggests treating individuals with nonclassic congenital adrenal hyperplasia who show symptoms, especially those related to excess male hormones.

Most 46XX CAH patients have female identity, but a few identify as male and may need treatment and surgery.

Cyproterone acetate effectively reduced hair growth in hirsute patients by lowering androgen levels and altering androgen metabolism.

High levels of cortisol in hair show long-term stress which can lower fertility in animals.

Cyproterone acetate was effective in treating acne, hirsutism, and alopecia with few side effects.

The study concluded that testing hormone levels after stimulation is not reliable for identifying carriers of 21-hydroxylase deficiency; genetic testing is necessary.

The document concludes that patient outcomes for Congenital Adrenal Hyperplasia are often not ideal because of poor management and a need for better diagnosis and treatment methods.

About 2.2% of women with symptoms of high male hormones have a mild form of congenital adrenal hyperplasia, and measuring a specific hormone level can accurately diagnose it.

Women with congenital adrenal hyperplasia have lower fertility, but with proper treatment, they can conceive successfully.

A balanced diet is crucial for normalizing hormone levels and managing obesity-related issues.

A woman with non-classic CAH had unusual heavy periods and high hormone levels, improved with treatment.

Non-classic congenital adrenal hyperplasia (NCCAH) can mimic PCOS and requires genetic testing for proper diagnosis and treatment.

Adults with classic congenital adrenal hyperplasia value medication that prevents weight gain from glucocorticoids the most.

The patient with severe hirsutism improved after being diagnosed with non-classic congenital adrenal hyperplasia and treated with corticosteroids.

Both treatments reduced androgen levels and hair growth in women with hirsutism.

Cyproterone acetate implants were more effective at reducing facial hair and improving skin in severe hirsutism than oral treatment.

Young women with nonclassic congenital adrenal hyperplasia may experience worse sexual function and mild depression compared to healthy women.

The document concludes that Nonclassic Congenital Adrenal Hyperplasia requires personalized treatment plans to manage symptoms and fertility, with glucocorticoids being a common therapy.

Consider rare forms of CAH for accurate diagnosis and treatment.